Titlebook: Childhood Leukemia: Present Problems and Future Prospects; Proceedings of the S Noboru Kobayashi,Tai Akera,Shuki Mizutani Conference procee

Favorable

R. H. Selvester,J. O. Wagner,H. B. Rubinrthern blot analyses to define the lineage-specific classification of childhood leukemia. Phenotypically, they were divided into B lineage (62.6%), T lineage (9.8%), nonlymphoid (14.3%), and uncertain lineage (13.3%). Two of the B-lineage ALL and two of the T-lineage ALL studied did not show immunog

SLING

矛盾

单独

拥护者

H. A. Snellen,H. C. Hemker,J. H. Bemmelgnancy. From the cautious use of single—agent chemotherapy in the 1950s, therapy has evolved to include the aggressive use of multiple agents. The results have been a progressive increase in remission frequency and remission duration. However, the most important outcome has been the increased cure r

Pruritus

Foundations of Quantum Mechanics,he most important predicting factor for success or failure. The acute leukemias still need adequate management, no matter how the geno- or phenotype of the leukemic clone is characterized. Enforced by the antileukemic efficacy of improved therapy, some risk factors of the past have lost importance,

Phonophobia

Quantum Theory of Chemical Reactionsology of vincristine, methotrexate, 6-mercaptopurine, cytarabine (cytosine arabinoside), and corticosteroids. The treating physician should be cognizant of the inter- and intrapatient variabilities in the pharmacokinetics and clinical effects of each of the drugs. The pharmacokinetics of other cance

expound

https://doi.org/10.1007/978-94-010-9716-14 patients, 82 (71.9%) achieved complete remission (CR). There was no difference in the CR rate among five different protocols proposed by CCLSG. The rates of continuous complete remission (COR.) at 20 months were 43.0 ± 10.7% (mean ± SE), 23.4 ± 11.0%, and 65.8 ± 10.6% in Regimen I, Regimen II, and

debris

Asperity